Arcala, Miralyn .

HRN: 10-43-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
CEFUROXIME 500MG (TAB)
07/25/2025
08/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: